The ASM signed onto a letter to Mr. António Guterres, United Nations Secretary-General and Dr. Margaret Chan, World Health Organization Director-General regarding the progress since the political declaration of the high level meeting on antimicrobial resistance (AMR) in the United Nations (UN) General Assembly in September 2016.
The ASM sent a letter to Senator Lamar Alexander (R-TN), chair and Senator Patty Murray (D-WA), ranking member of the Senate's health committee and Representative Greg Walden (R-OR), chair and Representative Frank Pallone Jr. (D-NJ), ranking member of the House Energy & Commerce Committee, and Texas Reps. Michael Burgess (R) and Gene Green (D), chairman and ranking member of the subcommittee on health regarding their “Dear Colleague” letter to their colleagues highlighting the benefits of vaccines.
Effective October 2016, the Centers for Disease Control and Prevention added Bacillus cereus biovar anthracis as a Tier 1 select agent to the list of select agents and toxins. Sentinel laboratories should continue using the existing ASM Sentinel Level Clinical Laboratory Guidelines for Suspected Agents of Bioterrorism and Emerging Infectious Diseases, Bacillus anthracis with new recommendations suggested here.
The ASM signed onto a letter to President Trump and Congressional leadership, urging the completion of an FY 2017 spending package that includes $34.1 billion for the National Institutes of Health (NIH). The letter was signed by 260 patient, medical, scientific, academic, and research organizations.